Pharmacological-based translational induction of transgene expression in mammalian cells

EMBO Reports

Volumn 5, Issue 7, 2004, Pages 721-727

  Boutonnet, Christel ^a,b   Boijoux, Olivier ^c   Bernat, Sandra ^b   Kharrat, Abdelhakkim ^b   Favre, Gilles ^c   Faye, Jean Charles ^c   Vagner, Stéphan ^a  

^a CHU RANGUEIL   (France)

^b MILLEGEN SA   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Inducible gene expression; Protein prenylation; Translation

Indexed keywords

COAT PROTEIN; HYBRID PROTEIN; INITIATION FACTOR; INITIATION FACTOR 4G; MESSENGER RNA; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; RNA BINDING PROTEIN;

ARTICLE; BACTERIOPHAGE; BINDING SITE; CANCER CELL CULTURE; CISTRON; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAMMAL CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN SECRETION; RIBOSOME; TRANSGENE; TRANSLATION INITIATION; TRANSLATION REGULATION;

CHIMAERA; EUKARYOTA; MAMMALIA;

EID: 4444376858     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.7400170     Document Type: Article

References (19)

1. Bardwell VJ, Wickens M (1990) Purification of RNA and RNA-protein complexes by an R17 coat protein affinity method. Nucleic Acids Res 18: 6587-6594
2. Bonnal S, Boutonnet C, Prado-Lourenco L, Vagner S (2003) IRESdb: the Internal Ribosome Entry Site database. Nucleic Acids Res 31: 427-428
3. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D, Ivanov IE, Philips MR (1999) Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98: 69-80
4. Cox AD, Hisaka MM, Buss JE, Der CJ (1992) Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein. Mol Cell Biol 12: 2606-2615
5. Creancier L, Morello D, Mercier P, Prats AC (2000) Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J Cell Biol 150: 275-281
6. De Gregorio E, Preiss T, Hentze MW (1999) Translation driven by an elF4G core domain in vivo. EMBO J 18: 4865-4874
7. Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, Favre G, Couderc B (2000) The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Cancer Gone Ther 7: 1543-1556
8. Fussenegger M, Schlatter S, Datwyler D, Mazur X, Bailey JE (1998) Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 16: 468-472
9. Gray NK, Wickens M (1998) Control of translation initiation in animals. Annu Rev Cell Dev Biol 14: 399-458
10. Johnston SR (2001) Farnesyl transferase inhibitors: a novel targeted therapy for cancer. Lancet Oncol 2: 18-26
11. Mills AA (2001) Changing colors in mice: an inducible system that delivers. Genes Dev 15: 1461-1467
12. Miquel K, Pradines A, Sun J, Qian Y, Hamilton AD, Sebti SM, Favre G (1997) GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. Cancer Res 57: 1846-1850
13. Sebti SM, Hamilton AD (2000) Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies. Oncogene 19: 6584-6593
14. Singh SB, Lingham RB (2002) Current progress on farnesyl protein transferase inhibitors. Curr Opin Drug Discov Dev 5: 225-244
15. Vagner S, Galy B, Pyronnet S (2001) Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites. EMBO Rep 2: 893-898
16. Weber W, Fussenegger M (2002) Artificial mammalian gene regulation networks - novel approaches for gene therapy and bioengineering. J Biotechnol 98: 161-187
17. Wen XY, Mandelbaum S, Li ZH, Hitt M, Graham FL, Hawley TS, Hawley RG, Stewart AK (2001) Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma. Cancer Gene Ther 8: 361-370
18. Werstuck G, Green MR (1998) Controlling gene expression in living cells through small molecule-RNA interactions. Science 282: 296-298
19. Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65: 241-269